COMPLETED

Safety of Xeloda in Solid Tumours

NCT02479217•Hoffmann-La Roche

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Metastatic Breast Cancer, Colon Cancer

Interventions

Docetaxel

Xeloda

Locations

1

Serbia

Locations (1)

Kamenitz, Serbia

Key Dates

Start Date

July 1, 2006

Primary Completion Date

June 1, 2009

Completion Date

June 1, 2009

Last Updated

February 17, 2017

Sponsors

Lead Sponsor

Hoffmann-La Roche

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 17, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions